1-(carboxymethylthio)tetradecane has been researched along with Benign Neoplasms, Brain in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berge, K; Berge, RK; Flindt, EN; Kristiansen, K; Madsen, L; Rasmussen, TH; Tronstad, KJ | 1 |
1 other study(ies) available for 1-(carboxymethylthio)tetradecane and Benign Neoplasms, Brain
Article | Year |
---|---|
Tetradecylthioacetic acid inhibits growth of rat glioma cells ex vivo and in vivo via PPAR-dependent and PPAR-independent pathways.
Topics: Animals; Antioxidants; Apoptosis; Blotting, Western; Brain Neoplasms; Cell Division; Cytochrome c Group; DNA Primers; Gene Expression; Glioma; Glutathione; In Vitro Techniques; Ligands; Male; Microscopy, Fluorescence; Mitochondria; Plasmids; Rats; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Sulfides; Transcription Factors; Transfection; Tumor Cells, Cultured | 2001 |